Do Non-participants at Screening have a Different Threshold for an Acceptable Benefit–Harm Ratio than Participants? Results of a Discrete Choice Experiment-Reference-Cited by-同舟云学术

Do Non-participants at Screening have a Different Threshold for an Acceptable Benefit–Harm Ratio than Participants? Results of a Discrete Choice Experiment

Published:2019-06-05 Issue:5 Volume:12 Page:491-501
ISSN:1178-1653
Container-title:The Patient - Patient-Centered Outcomes Research
language:en
Short-container-title:Patient

Author:

Hansen Tina Birgitte^ORCID,Lindholt Jes Sanddal,Diederichsen Axel,Søgaard Rikke

Funder

Region Sjælland

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1007/s40271-019-00364-z.pdf

Reference45 articles.

1. Robson J, Dostal I, Sheikh A, Eldridge S, Madurasinghe V, Griffiths C, et al. The NHS health check in England: an evaluation of the first 4 years. BMJ Open. 2016;13(6):e008840.

2. Linne A, Leander K, Lindström D, Törnberg S, Hultgren R. Reasons for non-participation in population-based abdominal aortic aneurysm screening. Br J Surg. 2014;101:481–7.

3. Lindholt JS, Søgaard R. Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet. 2017;390:2256–65.

4. Diederichsen AC, Rasmussen LM, Søgaard R. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial. Trials. 2015;16:554.

5. Zarrouk M, Lundqvist A, Holst J, Troëng T, Gottsäter A. Cost-effectiveness of screening for abdominal aortic aneurysm in combination with medical intervention in patients with small aneurysms. Eur J Vasc Endovasc Surg. 2016;51:766–73.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost effectiveness of population screening vs. no screening for cardiovascular disease: the Danish Cardiovascular Screening trial (DANCAVAS);European Heart Journal;2022-08-27

2. Methodology to derive preference for health screening programmes using discrete choice experiments: a scoping review;BMC Health Services Research;2022-08-24

3. Pharmacological Preventive Potential Among Attenders at Vascular Screening: Findings from the VIVA Trial;European Journal of Vascular and Endovascular Surgery;2020-04